Here Comes the Booming Chinese Biotech Sector
You’ve heard about Chinese EVs. You’ve heard about Chinese batteries and solar panels. And recently you learned that China is near the cutting edge of AI research. Here’s another category: biotech. In 2019, the Chinese share of molecules licensed to Big Pharma companies was 0%. In 2024, it’s now 31%. On this episode…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from Odd Lots
See all episodes →Similar episodes from other shows
More like Odd Lots →
57%China's booming biotech, from a brain implant to drug discovery
The Chinese Cancer Fix
Can America Win The AI Biotech Race Against China? | Lada Nuzhna & Elliot Hershberg
EP 32: AI Discovers Drugs: The 2026 Clinical Trial Moment for AI in Biotech
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.